6 [49] S. Sever, M. M. Altintas, S. R. Nankoe et al., “Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease,” Journal of Clinical Investigation, vol. 117, no. 8, pp. 2095–2104, 2007. [50] J. Reiser, G. von Gersdorﬀ, M. Loos et al., “Induction of B7-1 in podocytes is associated with nephrotic syndrome,” Journal of Clinical Investigation, vol. 113, no. 10, pp. 1390–1397, 2004. [51] J. Reiser and P. Mundel, “Danger signaling by glomerular podocytes deﬁnes a novel function of inducible B7-1 in the pathogenesis of nephrotic syndrome,” Journal of the American Society of Nephrology, vol. 15, no. 9, pp. 2246–2248, 2004. [52] S. Z. Li, B. W. McDill, P. A. Kovach et al., “Calcineurin-NFATc signaling pathway regulates AQP2 expression in response to calcium signals and osmotic stress,” American Journal of Physiology, vol. 292, no. 5, pp. C1606–C1616, 2007. [53] M. Anderson, J. M. Suh, E. Y. Kim, and S. E. Dryer, “Functional NMDA receptors with atypical properties are expressed in podocytes,” American Journal of Physiology, vol. 300, no. 1, pp. C22–C32, 2011. [54] E. Y. Kim, J. M. Suh, Y. H. Chiu, and S. E. Dryer, “Regulation of podocyte BKCa channels by synaptopodin, Rho, and actin microﬁlaments,” American Journal of Physiology, vol. 299, no. 3, pp. F594–F604, 2010. [55] A. Greka and P. Mundel, “Balancing calcium signals through TRPC5 and TRPC6 in podocytes,” Journal of the American Society of Nephrology, vol. 22, no. 11, pp. 1969–1980, 2011. [56] Y. Harita, H. Kurihara, H. Kosako et al., “Phosphorylation of nephrin triggers Ca2+ signaling by recruitment and activation of phospholipase C-γ1,” Journal of Biological Chemistry, vol. 284, no. 13, pp. 8951–8962, 2009. [57] J. Vassiliadis, C. Bracken, D. Matthews, S. O’Brien, S. Schiavi, and S. Wawersik, “Calcium mediates glomerular ﬁltration through calcineurin and mTORC2/Akt signaling,” Journal of the American Society of Nephrology, vol. 22, no. 8, pp. 1453– 1461, 2011. [58] J. Schlo¨ndorﬀ, D. del Camino, R. Carrasquillo, V. Lacey, and M. R. Pollak, “TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription,” American Journal of Physiol- ogy, vol. 296, no. 3, pp. C558–C569, 2009. [59] M. J. Moeller, S. K. Sanden, A. Sooﬁ, R. C. Wiggins, and L. B. Holzman, “Podocyte-speciﬁc expression of Cre recombinase in transgenic mice,” Genesis, vol. 35, no. 1, pp. 39–42, 2003. [60] G. Belteki, J. Haigh, N. Kabacs et al., “Conditional and inducible transgene expression in mice through the combi- natorial use of Cre-mediated recombination and tetracycline induction,” Nucleic Acids Research, vol. 33, no. 5, p. e51, 2005. [61] D. Tian, S. M. P. Jacobo, D. Billing et al., “Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels,” Science Signaling, vol. 3, no. 145, article ra77, 2010. [62] L. Wang, J. H. Chang, S. Y. Paik, Y. Tang, W. Eisner, and R. F. Spurney, “Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo,” Molecular Endocrinology, vol. 25, no. 8, pp. 1376–1386, 2011. [63] M. M. Winslow, M. Pan, M. Starbuck et al., “Cal- cineurin/NFAT signaling in osteoblasts regulates bone mass,” Developmental Cell, vol. 10, no. 6, pp. 771–782, 2006. [64] M. Pan, M. M. Winslow, L. Chen, A. Kuo, D. Felsher, and G. R. Crabtree, “Enhanced NFATc1 nuclear occupancy causes T cell activation independent of CD28 costimulation,” Journal of Immunology, vol. 178, no. 7, pp. 4315–4321, 2007. International Journal of Nephrology [65] J. J. Heit, A. A. Apelqvist, X. Gu et al., “Calcineurin/NFAT signalling regulates pancreatic β-cell growth and function,” Nature, vol. 443, no. 7109, pp. 345–349, 2006. [66] M. Y. Lee, S. M. Garvey, A. S. Baras et al., “Integrative genomics identiﬁes DSCR1 (RCAN1) as a novel NFAT- dependent mediator of phenotypic modulation in vascular smooth muscle cells,” Human Molecular Genetics, vol. 19, no. 3, pp. 468–479, 2009. [67] Q. Liu, J. C. Busby, and J. D. Molkentin, “Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin deﬁnes a signalling nodal control point,” Nature Cell Biology, vol. 11, no. 2, pp. 154–161, 2009. [68] C. Dai, D. B. Stolz, L. P. Kiss, S. P. Monga, L. B. Holzman, and Y. Liu, “Wnt/β-catenin signaling promotes podocyte dysfunction and albuminuria,” Journal of the American Society of Nephrology, vol. 20, no. 9, pp. 1997–2008, 2009.